{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T01:06:05Z","timestamp":1768093565843,"version":"3.49.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T00:00:00Z","timestamp":1578268800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T00:00:00Z","timestamp":1578268800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Fapesp","doi-asserted-by":"crossref","award":["2017\/03489-1"],"award-info":[{"award-number":["2017\/03489-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001807","name":"Fapesp","doi-asserted-by":"crossref","award":["2015\/06458-4"],"award-info":[{"award-number":["2015\/06458-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001807","name":"Fapesp","doi-asserted-by":"crossref","award":["2016\/02040-8"],"award-info":[{"award-number":["2016\/02040-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002322","name":"Capes","doi-asserted-by":"crossref","award":["funding code 001"],"award-info":[{"award-number":["funding code 001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The NEK serine\/threonine protein kinases are involved in cell cycle checkpoints, DNA damage repair, and apoptosis. Alterations in these pathways are frequently associated with cell malignant cellular transformations. Thyroid cancer is the most common malignant tumour in the endocrine system. Despite good treatment methods, the number of cases has increased significantly in recent years. Here, we studied the expression of NEK1, NEK2, NEK3, and NEK5 in different types of normal and malignant tissues, using tissue microarray analysis, and identified NEKs as potential markers in thyroid malignancy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The studied cases comprised multiple cancer tissue microarrays, including breast, colon, esophagus, kidney, lung, pancreas, prostate, stomach, thyroid and uterine cervix, as well as 281 patients who underwent thyroid resection for thyroid cancer or thyroid nodules. The expression of NEK1, NEK2, NEK3, and NEK5 was analyzed by immunohistochemistry. The expression pattern was evaluated in terms of intensity by two methods, semiquantitative and quantitative, and was compared between normal and cancer tissue.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We analysed the expression of each member of the NEK family in a tissue-dependent manner. Compared to normal tissue, most of the evaluated proteins showed lower expression in lung tumour. However, in the thyroid, the expression was higher in malignant tissue, especially for NEK 1, NEK3 and NEK5. Concerning characteristics of the thyroid tumour, such as aggressiveness, NEK1 expression was higher in tumours with multifocality and in patients with lymph node metastasis. NEK3 expression was stronger in patients with stage II, that involved metastasis. NEK5, on the other hand, showed high expression in patients with invasion and metastasis and in patients with tumour size &gt;\u20094\u2009cm. Furthermore, this work, demonstrated for the first time a high specificity and sensitivity of over-expression of NEK1 in classical and follicular variants of papillary thyroid cancer and NEK3 in tall-cell papillary thyroid cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Taken together, the NEK protein kinases emerge as important proteins in thyroid cancer development and may help to identify malignancy and aggressiveness features during diagnosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p>This study was retrospectively registered.\u00a0<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.accamargo.org.br\/cientistas-pesquisadores\/comite-de-etica-em-pequisa-cep\">www.accamargo.org.br\/cientistas-pesquisadores\/comite-de-etica-em-pequisa-cep<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12885-019-6408-4","type":"journal-article","created":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T19:03:05Z","timestamp":1578337385000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Expression of the NEK family in normal and cancer tissue: an immunohistochemical study"],"prefix":"10.1186","volume":"20","author":[{"given":"Talita Diniz","family":"Melo-Hanchuk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana Bonjiorno","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas Leite","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando Augusto","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura Sterian","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Vassallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9419-0145","authenticated-orcid":false,"given":"J\u00f6rg","family":"Kobarg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,6]]},"reference":[{"issue":"10","key":"6408_CR1","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0968-0004(02)02179-5","volume":"27","author":"G Manning","year":"2002","unstructured":"Manning G, et al. Evolution of protein kinase signaling from yeast to man. Trends Biochem Sci. 2002;27(10):514\u201320.","journal-title":"Trends Biochem Sci"},{"issue":"7","key":"6408_CR2","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nrd2907","volume":"8","author":"S Lapenna","year":"2009","unstructured":"Lapenna S, Giordano A. Cell cycle kinases as therapeutic targets for cancer. Nat Rev Drug Discov. 2009;8(7):547\u201366.","journal-title":"Nat Rev Drug Discov"},{"issue":"9\u201310","key":"6408_CR3","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1101\/gad.314351.118","volume":"32","author":"MS Levine","year":"2018","unstructured":"Levine MS, Holland AJ. The impact of mitotic errors on cell proliferation and tumourigenesis. Genes Dev. 2018;32(9\u201310):620\u201338.","journal-title":"Genes Dev"},{"issue":"16","key":"6408_CR4","doi-asserted-by":"publisher","first-page":"8147","DOI":"10.1158\/0008-5472.CAN-05-3489","volume":"66","author":"M Capra","year":"2006","unstructured":"Capra M, et al. Frequent alterations in the expression of serine\/threonine kinases in human cancers. Cancer Res. 2006;66(16):8147\u201354.","journal-title":"Cancer Res"},{"issue":"2","key":"6408_CR5","first-page":"141","volume":"5","author":"GV Meirelles","year":"2014","unstructured":"Meirelles GV, et al. \"stop ne(c) king around\": how interactomics contributes to functionally characterize Nek family kinases. World J Biol Chem. 2014;5(2):141\u201360.","journal-title":"World J Biol Chem"},{"issue":"Pt 22","key":"6408_CR6","doi-asserted-by":"publisher","first-page":"5161","DOI":"10.1242\/jcs.02681","volume":"118","author":"LM Quarmby","year":"2005","unstructured":"Quarmby LM, Mahjoub MR. Caught Nek-ing: cilia and centrioles. J Cell Sci. 2005;118(Pt 22):5161\u20139.","journal-title":"J Cell Sci"},{"issue":"10","key":"6408_CR7","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1002\/j.1460-2075.1992.tb05435.x","volume":"11","author":"K Letwin","year":"1992","unstructured":"Letwin K, et al. A mammalian dual specificity protein kinase, Nek1, is related to the NIMA cell cycle regulator and highly expressed in meiotic germ cells. EMBO J. 1992;11(10):3521\u201331.","journal-title":"EMBO J"},{"issue":"6","key":"6408_CR8","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.21037\/tau.2017.10.04","volume":"6","author":"KH Pang","year":"2017","unstructured":"Pang KH, et al. Opportunities of next-generation sequencing in non-muscle invasive bladder cancer outcome prediction. Transl Androl Urol. 2017;6(6):1043\u20138.","journal-title":"Transl Androl Urol"},{"issue":"8","key":"6408_CR9","doi-asserted-by":"publisher","first-page":"e0136812","DOI":"10.1371\/journal.pone.0136812","volume":"10","author":"L Cabral de Almeida Cardoso","year":"2015","unstructured":"Cabral de Almeida Cardoso L, et al. Array CGH Analysis of Paired Blood and Tumour Samples from Patients with Sporadic Wilms Tumour. PLoS One. 2015;10(8):e0136812.","journal-title":"PLoS One"},{"issue":"19","key":"6408_CR10","doi-asserted-by":"publisher","first-page":"28592","DOI":"10.18632\/oncotarget.8696","volume":"7","author":"TT Dang","year":"2016","unstructured":"Dang TT, et al. DeltaNp63alpha induces the expression of FAT2 and slug to promote tumour invasion. Oncotarget. 2016;7(19):28592\u2013611.","journal-title":"Oncotarget"},{"issue":"4","key":"6408_CR11","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1210\/me.2004-0443","volume":"19","author":"SL Miller","year":"2005","unstructured":"Miller SL, et al. Novel association of Vav2 and Nek3 modulates signaling through the human prolactin receptor. Mol Endocrinol. 2005;19(4):939\u201349.","journal-title":"Mol Endocrinol"},{"issue":"20","key":"6408_CR12","doi-asserted-by":"publisher","first-page":"7370","DOI":"10.1158\/0008-5472.CAN-04-0960","volume":"64","author":"DG Hayward","year":"2004","unstructured":"Hayward DG, et al. The centrosomal kinase Nek2 displays elevated levels of protein expression in human breast cancer. Cancer Res. 2004;64(20):7370\u20136.","journal-title":"Cancer Res"},{"issue":"3","key":"6408_CR13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009630","volume":"97","author":"Y Cao","year":"2018","unstructured":"Cao Y, et al. Overexpression of NEK3 is associated with poor prognosis in patients with gastric cancer. Medicine (Baltimore). 2018;97(3):e9630.","journal-title":"Medicine (Baltimore)"},{"issue":"20","key":"6408_CR14","doi-asserted-by":"publisher","first-page":"32990","DOI":"10.18632\/oncotarget.16518","volume":"8","author":"AS Nikitina","year":"2017","unstructured":"Nikitina AS, et al. Novel RNA biomarkers of prostate cancer revealed by RNA-seq analysis of formalin-fixed samples obtained from Russian patients. Oncotarget. 2017;8(20):32990\u20133001.","journal-title":"Oncotarget"},{"issue":"2","key":"6408_CR15","first-page":"530","volume":"23","author":"FB Zhang","year":"2019","unstructured":"Zhang FB, et al. MiR-1299 functions as a tumour suppressor to inhibit the proliferation and metastasis of prostate cancer by targeting NEK2. Eur Rev Med Pharmacol Sci. 2019;23(2):530\u20138.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"6408_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12894-015-0085-7","volume":"15","author":"YR Zeng","year":"2015","unstructured":"Zeng YR, et al. Overexpression of NIMA-related kinase 2 is associated with progression and poor prognosis of prostate cancer. BMC Urol. 2015;15:90.","journal-title":"BMC Urol"},{"key":"6408_CR17","unstructured":"Society, A.C. Key Statistics for Thyroid Cancer. 2018 [cited 2018 10\/04]; Available from: https:\/\/http:\/\/www.cancer.org\/cancer\/thyroid-cancer\/about\/key-statistics.html. Accessed 4 Oct 2018."},{"key":"6408_CR18","unstructured":"Key Statistics for Thyroid Cancer. 2018 [cited 2018 10\/04\/18]; Available from: https:\/\/http:\/\/www.cancer.org\/cancer\/thyroid-cancer\/about\/key-statistics.html. Accessed 4 Oct 2018."},{"key":"6408_CR19","first-page":"2832980","volume":"2016","author":"H Zhang","year":"2016","unstructured":"Zhang H, Gao B, Shi B. Identification of differentially expressed kinase and screening potential anticancer drugs in papillary thyroid carcinoma. Dis Markers. 2016;2016:2832980.","journal-title":"Dis Markers"},{"issue":"1","key":"6408_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1039\/C7MD00510E","volume":"9","author":"CI Wells","year":"2018","unstructured":"Wells CI, et al. In depth analysis of kinase cross screening data to identify chemical starting points for inhibition of the Nek family of kinases. Medchemcomm. 2018;9(1):44\u201366.","journal-title":"Medchemcomm"},{"issue":"Pt 19","key":"6408_CR21","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1242\/jcs.111195","volume":"125","author":"AM Fry","year":"2012","unstructured":"Fry AM, et al. Cell cycle regulation by the NEK family of protein kinases. J Cell Sci. 2012;125(Pt 19):4423\u201333.","journal-title":"J Cell Sci"},{"issue":"5","key":"6408_CR22","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"issue":"2","key":"6408_CR23","doi-asserted-by":"publisher","first-page":"257","DOI":"10.4161\/cc.8.2.7551","volume":"8","author":"Y Chen","year":"2009","unstructured":"Chen Y, Craigen WJ, Riley DJ. Nek1 regulates cell death and mitochondrial membrane permeability through phosphorylation of VDAC1. Cell Cycle. 2009;8(2):257\u201367.","journal-title":"Cell Cycle"},{"issue":"3","key":"6408_CR24","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.bbrc.2010.03.077","volume":"394","author":"Y Chen","year":"2010","unstructured":"Chen Y, et al. Phosphorylation by Nek1 regulates opening and closing of voltage dependent anion channel 1. Biochem Biophys Res Commun. 2010;394(3):798\u2013803.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"6408_CR25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.canlet.2013.02.012","volume":"335","author":"HJ Jee","year":"2013","unstructured":"Jee HJ, et al. The inhibition of Nek6 function sensitizes human cancer cells to premature senescence upon serum reduction or anticancer drug treatment. Cancer Lett. 2013;335(1):175\u201382.","journal-title":"Cancer Lett"},{"issue":"5","key":"6408_CR26","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.molcel.2017.01.015","volume":"65","author":"R Tan","year":"2017","unstructured":"Tan R, et al. Nek7 protects telomeres from oxidative DNA damage by phosphorylation and stabilization of TRF1. Mol Cell. 2017;65(5):818\u201331 e5.","journal-title":"Mol Cell"},{"issue":"3\u20134","key":"6408_CR27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.bbrc.2013.04.105","volume":"442","author":"Y Kaneta","year":"2013","unstructured":"Kaneta Y, Ullrich A. NEK9 depletion induces catastrophic mitosis by impairment of mitotic checkpoint control and spindle dynamics. Biochem Biophys Res Commun. 2013;442(3\u20134):139\u201346.","journal-title":"Biochem Biophys Res Commun"},{"issue":"18","key":"6408_CR28","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1038\/onc.2013.183","volume":"33","author":"P Cappello","year":"2014","unstructured":"Cappello P, et al. Role of Nek2 on centrosome duplication and aneuploidy in breast cancer cells. Oncogene. 2014;33(18):2375\u201384.","journal-title":"Oncogene"},{"issue":"6","key":"6408_CR29","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.cellsig.2015.02.021","volume":"27","author":"TD Melo Hanchuk","year":"2015","unstructured":"Melo Hanchuk TD, et al. Nek5 interacts with mitochondrial proteins and interferes negatively in mitochondrial mediated cell death and respiration. Cell Signal. 2015;27(6):1168\u201377.","journal-title":"Cell Signal"},{"issue":"10","key":"6408_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140975","volume":"10","author":"SR Sabir","year":"2015","unstructured":"Sabir SR, et al. Loss of Nek11 prevents G2\/M arrest and promotes cell death in HCT116 colorectal Cancer cells exposed to therapeutic DNA damaging agents. PLoS One. 2015;10(10):e0140975.","journal-title":"PLoS One"},{"issue":"1","key":"6408_CR31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1476-4598-10-5","volume":"10","author":"Y Chen","year":"2011","unstructured":"Chen Y, et al. Mutation of NIMA-related kinase 1 (NEK1) leads to chromosome instability. Mol Cancer. 2011;10(1):5.","journal-title":"Mol Cancer"},{"key":"6408_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2013.34","volume":"2","author":"TK Das","year":"2013","unstructured":"Das TK, et al. Centrosomal kinase Nek2 cooperates with oncogenic pathways to promote metastasis. Oncogenesis. 2013;2:e69.","journal-title":"Oncogenesis"},{"issue":"24","key":"6408_CR33","doi-asserted-by":"publisher","first-page":"5839","DOI":"10.1242\/dev.00173","volume":"129","author":"S Liu","year":"2002","unstructured":"Liu S, et al. A defect in a novel Nek-family kinase causes cystic kidney disease in the mouse and in zebrafish. Development. 2002;129(24):5839\u201346.","journal-title":"Development"},{"issue":"1","key":"6408_CR34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1073\/pnas.97.1.217","volume":"97","author":"P Upadhya","year":"2000","unstructured":"Upadhya P, et al. Mutations in a NIMA-related kinase gene, Nek1, cause pleiotropic effects including a progressive polycystic kidney disease in mice. Proc Natl Acad Sci U S A. 2000;97(1):217\u201321.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"6408_CR35","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1681\/ASN.V10122534","volume":"10","author":"C Vogler","year":"1999","unstructured":"Vogler C, et al. Clinical and pathologic findings in two new allelic murine models of polycystic kidney disease. J Am Soc Nephrol. 1999;10(12):2534\u20139.","journal-title":"J Am Soc Nephrol"},{"issue":"23","key":"6408_CR36","doi-asserted-by":"publisher","first-page":"9742","DOI":"10.1158\/0008-5472.CAN-10-1907","volume":"70","author":"AC Antoniou","year":"2010","unstructured":"Antoniou AC, et al. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Res. 2010;70(23):9742\u201354.","journal-title":"Cancer Res"},{"issue":"1","key":"6408_CR37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jdermsci.2016.10.006","volume":"85","author":"T Kaji","year":"2017","unstructured":"Kaji T, et al. Comparative study on driver mutations in primary and metastatic melanomas at a single Japanese institute: a clue for intra- and inter-tumour heterogeneity. J Dermatol Sci. 2017;85(1):51\u20137.","journal-title":"J Dermatol Sci"},{"issue":"7","key":"6408_CR38","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1002\/jso.23717","volume":"110","author":"CP Neal","year":"2014","unstructured":"Neal CP, et al. Overexpression of the Nek2 kinase in colorectal cancer correlates with beta-catenin relocalization and shortened cancer-specific survival. J Surg Oncol. 2014;110(7):828\u201338.","journal-title":"J Surg Oncol"},{"issue":"3","key":"6408_CR39","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1007\/s13277-015-4131-6","volume":"37","author":"E Kasap","year":"2016","unstructured":"Kasap E, et al. The potential role of the NEK6, AURKA, AURKB, and PAK1 genes in adenomatous colorectal polyps and colorectal adenocarcinoma. Tumour Biol. 2016;37(3):3071\u201380.","journal-title":"Tumour Biol"},{"issue":"4","key":"6408_CR40","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.3892\/or.2015.4187","volume":"34","author":"E Gerceker","year":"2015","unstructured":"Gerceker E, et al. Never in mitosis gene A-related kinase 6 and aurora kinase a: new gene biomarkers in the conversion from ulcerative colitis to colorectal cancer. Oncol Rep. 2015;34(4):1905\u201314.","journal-title":"Oncol Rep"},{"key":"6408_CR41","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.gene.2003.12.002","volume":"328","author":"AJ Bowers","year":"2004","unstructured":"Bowers AJ, Boylan JF. Nek8, a NIMA family kinase member, is overexpressed in primary human breast tumours. Gene. 2004;328:135\u201342.","journal-title":"Gene"},{"issue":"32","key":"6408_CR42","doi-asserted-by":"publisher","first-page":"4668","DOI":"10.1038\/sj.onc.1210264","volume":"26","author":"SL Miller","year":"2007","unstructured":"Miller SL, et al. Nek3 kinase regulates prolactin-mediated cytoskeletal reorganization and motility of breast cancer cells. Oncogene. 2007;26(32):4668\u201378.","journal-title":"Oncogene"},{"issue":"3","key":"6408_CR43","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s10549-017-4652-3","volume":"168","author":"M Nuncia-Cantarero","year":"2018","unstructured":"Nuncia-Cantarero M, et al. Functional transcriptomic annotation and protein-protein interaction network analysis identify NEK2, BIRC5, and TOP2A as potential targets in obese patients with luminal a breast cancer. Breast Cancer Res Treat. 2018;168(3):613\u201323.","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"6408_CR44","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1002\/mc.22982","volume":"58","author":"J Pei","year":"2019","unstructured":"Pei J, et al. NEK5 promotes breast cancer cell proliferation through up-regulation of Cyclin A2. Mol Carcinog. 2019;58(6):933\u201343.","journal-title":"Mol Carcinog"},{"issue":"10","key":"6408_CR45","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1016\/j.prp.2018.07.030","volume":"214","author":"Z He","year":"2018","unstructured":"He Z, et al. Overexpression of NIMA-related kinase 6 (NEK6) contributes to malignant growth and dismal prognosis in human breast Cancer. Pathol Res Pract. 2018;214(10):1648\u201354.","journal-title":"Pathol Res Pract"},{"issue":"3","key":"6408_CR46","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1158\/0008-5472.CAN-16-0455","volume":"77","author":"AD Choudhury","year":"2017","unstructured":"Choudhury AD, et al. Castration resistance in prostate Cancer is mediated by the kinase NEK6. Cancer Res. 2017;77(3):753\u201365.","journal-title":"Cancer Res"},{"issue":"1","key":"6408_CR47","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1128\/MCB.00648-10","volume":"31","author":"LS Moniz","year":"2011","unstructured":"Moniz LS, Stambolic V. Nek10 mediates G2\/M cell cycle arrest and MEK autoactivation in response to UV irradiation. Mol Cell Biol. 2011;31(1):30\u201342.","journal-title":"Mol Cell Biol"},{"issue":"6","key":"6408_CR48","doi-asserted-by":"publisher","first-page":"R110","DOI":"10.1186\/bcr3052","volume":"13","author":"AM Mulligan","year":"2011","unstructured":"Mulligan AM, et al. Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the consortium of investigators of modifiers of BRCA1\/2. Breast Cancer Res. 2011;13(6):R110.","journal-title":"Breast Cancer Res"},{"issue":"14","key":"6408_CR49","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1016\/j.febslet.2013.05.049","volume":"587","author":"K Shimizu","year":"2013","unstructured":"Shimizu K, Sawasaki T. Nek5, a novel substrate for caspase-3, promotes skeletal muscle differentiation by up-regulating caspase activity. FEBS Lett. 2013;587(14):2219\u201325.","journal-title":"FEBS Lett"},{"issue":"10","key":"6408_CR50","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.febslet.2008.03.036","volume":"582","author":"O Shalom","year":"2008","unstructured":"Shalom O, et al. The mammalian Nek1 kinase is involved in primary cilium formation. FEBS Lett. 2008;582(10):1465\u201370.","journal-title":"FEBS Lett"},{"issue":"9","key":"6408_CR51","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1002\/ijc.24180","volume":"124","author":"A Szponar","year":"2009","unstructured":"Szponar A, et al. Three genetic developmental stages of papillary renal cell tumours: duplication of chromosome 1q marks fatal progression. Int J Cancer. 2009;124(9):2071\u20136.","journal-title":"Int J Cancer"},{"issue":"2","key":"6408_CR52","doi-asserted-by":"publisher","first-page":"204","DOI":"10.4103\/2230-8210.93737","volume":"16","author":"G Basu","year":"2012","unstructured":"Basu G, Mohapatra A. Interactions between thyroid disorders and kidney disease. Indian J Endocrinol Metab. 2012;16(2):204\u201313.","journal-title":"Indian J Endocrinol Metab"},{"issue":"5","key":"6408_CR53","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00259-003-1448-y","volume":"31","author":"E Berthe","year":"2004","unstructured":"Berthe E, et al. Risk of second primary cancer following differentiated thyroid cancer. Eur J Nucl Med Mol Imaging. 2004;31(5):685\u201391.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"6408_CR54","doi-asserted-by":"publisher","first-page":"133","DOI":"10.7326\/0003-4819-115-2-133","volume":"115","author":"J Robbins","year":"1991","unstructured":"Robbins J, et al. Thyroid cancer: a lethal endocrine neoplasm. Ann Intern Med. 1991;115(2):133\u201347.","journal-title":"Ann Intern Med"},{"issue":"Suppl 2","key":"6408_CR55","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1186\/1471-2482-13-S2-S44","volume":"13","author":"A Guerra","year":"2013","unstructured":"Guerra A, et al. Genetic mutations in the treatment of anaplastic thyroid cancer: a systematic review. BMC Surg. 2013;13(Suppl 2):S44.","journal-title":"BMC Surg"},{"issue":"10","key":"6408_CR56","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nrendo.2011.142","volume":"7","author":"YE Nikiforov","year":"2011","unstructured":"Nikiforov YE, Nikiforova MN. Molecular genetics and diagnosis of thyroid cancer. Nat Rev Endocrinol. 2011;7(10):569\u201380.","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"6408_CR57","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.bbrc.2016.05.156","volume":"476","author":"J Zhu","year":"2016","unstructured":"Zhu J, et al. Frequent Nek1 overexpression in human gliomas. Biochem Biophys Res Commun. 2016;476(4):522\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"6408_CR58","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.bbrc.2016.03.081","volume":"473","author":"Y Maimaiti","year":"2016","unstructured":"Maimaiti Y, et al. Aurora kinase a induces papillary thyroid cancer lymph node metastasis by promoting cofilin-1 activity. Biochem Biophys Res Commun. 2016;473(1):212\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"6408_CR59","doi-asserted-by":"publisher","first-page":"740","DOI":"10.4158\/EP-2018-0052","volume":"24","author":"Ilana Slutzky-Shraga","year":"2018","unstructured":"Slutzky-Shraga I, Sternov Y, Robenshtock E, Tzvetov G, Benbassat C, Hirsch D. Be Aware of the Patient With Benign Follicular Thyroid Lesion Histology and Rising Thyroglobulin Level. Endocr Pract. 2018;24(8):740-745. https:\/\/doi.org\/10.4158\/EP-2018-0052.","journal-title":"Endocrine Practice"},{"issue":"11","key":"6408_CR60","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1097\/00000478-200211000-00014","volume":"26","author":"Mitsuyoshi Hirokawa","year":"2002","unstructured":"Hirokawa M, Carney JA, Goellner JR et al. Observer variation of encapsulated follicular lesions of the thyroid gland. Am. J. Surg. Pathol. 2002;26:1508\u20131514.","journal-title":"The American Journal of Surgical Pathology"},{"issue":"11","key":"6408_CR61","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/S0046-8177(03)00403-9","volume":"34","author":"B Franc","year":"2003","unstructured":"Franc B. Interobserver and intraobserver reproducibility in the histopathology of follicular thyroid carcinoma. Human Pathology. 2003;34(11):1092-1100.","journal-title":"Human Pathology"},{"issue":"5","key":"6408_CR62","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1309\/044V86JN2W3CN5YB","volume":"126","author":"Theresa Scognamiglio","year":"2006","unstructured":"Scognamiglio T, et al. Diagnostic usefulness of HBME1, galectin-3, CK19, and CITED1 and evaluation of their expression in encapsulated lesions with questionable features of papillary thyroid carcinoma. Am J Clin Pathol. 2006;126(5):700\u20138.","journal-title":"American Journal of Clinical Pathology"},{"issue":"4","key":"6408_CR63","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1365-2559.2005.02221.x","volume":"47","author":"P S de Matos","year":"2005","unstructured":"de Matos PS, et al. Usefulness of HBME1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy. Histopathology. 2005;47(4):391\u2013401.","journal-title":"Histopathology"},{"issue":"9","key":"6408_CR64","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.5858\/arpa.2016-0550-RA","volume":"141","author":"Jennifer S. Woo","year":"2017","unstructured":"Woo JS, et al. Application of immunohistochemistry in the diagnosis of pulmonary and pleural neoplasms. Arch Pathol Lab Med. 2017;141(9):1195\u2013213.","journal-title":"Archives of Pathology & Laboratory Medicine"},{"issue":"2","key":"6408_CR65","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/1097-0142(197502)35:2<399::AID-CNCR2820350215>3.0.CO;2-V","volume":"35","author":"K. F. W. Hinson","year":"1975","unstructured":"Hinson KF, et al. An assessment of the World Health Organization classification of the histologic typing of lung tumours applied to biopsy and resectedmaterial. Cancer. 1975;35(2):399\u2013405.","journal-title":"Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6408-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-6408-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6408-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T03:12:51Z","timestamp":1665371571000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-6408-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,6]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["6408"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-6408-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,6]]},"assertion":[{"value":"11 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The studied cases comprise multiple cancer tissue microarrays which were purchased from a company and therefore do not require an ethics approval for their use.The thyroid samples consist of a retrospective study approved by the \u201cEthics Committee in Research from Hospital AC Camargo\u201d (#1259\/09-C). The original samples had been obtained by written informed consent of the patients. They agreed that the tissues are maintained in the \u201cbiobanco\u201d (=\u201cBioBank\u201d) of Cancer Hospital AC Camargo and made available to researchers.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interests regarding the publication of this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}